cjc-1295 ipamorelin side effects clinical studies combination Sublingual + vs Injectable: Which Form Should You Choose? CJC-1295 & Ipamorelin Ipamorelin Side Effects: Common Risks,

Marc Singer, MD, University of Illinois at Chicago, Chicago, IL

Patients considering IGF-1 LR3 should undergo comprehensive evaluation to determine whether peptide therapy is appropriate and whether safer alternatives may achieve similar goals

When a GHRH analogue (such as CJC-1295 No DAC) and a GHRP (such as ipamorelin) are administered together, the combined GH release substantially exceeds the sum of the individual responses a finding consistent with the well-established physiological synergism between the hypothalamic GHRH and ghrelin systems

[PubMed: 32115881] 265

Both are research compounds classified as not intended for human therapeutic use

This is one reason why many people prefer it